Series C - Frontier Medicines
Investment Firm
Overview
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Announced Date
Jun 25, 2024
Closed on Date
Jun 25, 2024
Funding Type
Series C
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
Frontier Medicines raised $20000000 on 2024-06-25 in Series C
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 19, 2021 |  Series B - Frontier Medicines | 10 | - | 88.5M |
| Jul 19, 2019 | Series B - Frontier Medicines | 6 | - | 88.5M |
| Feb 22, 2024 | Series C - Frontier Medicines | 6 | - | 80.0M |
| Jun 25, 2024 | Series C - Frontier Medicines | 2 | - | 20.0M |
Recent Activity
There is no recent news or activity for this profile.